• Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Enzo Biochem Inc

+ Add to Watchlist


5.9500 USD 0.2200 3.84%

As of 20:04:07 ET on 08/29/2014.

Snapshot for Enzo Biochem Inc (ENZ)

Open: 5.7300 Day's Range: 5.6700 - 5.9600 Volume: 194,854
Previous Close: 5.7300 52wk Range: 2.2500 - 5.9600 1-Yr Rtn: +143.85%

Stock Chart for ENZ

No chart data available.
  • ENZ:US 5.9500
  • 1D
  • 1M
  • 1Y
Interactive ENZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENZ

Current P/E Ratio (ttm) -
Estimated P/E(07/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2078
Est. EPS (USD) (07/2014) -0.2400
Est. PEG Ratio -
Market Cap (M USD) 260.76
Shares Outstanding (M) 43.83
30 Day Average Volume 239,349
Price/Book (mrq) 6.8749
Price/Sale (ttm) 2.6243
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENZ

Enzo Biochem, Inc. researches, develops, and manufactures health care products based on molecular biology and genetic engineering techniques. The Company also provides diagnostic services to the medical community. Enzo Biochem's labeling and detection products for gene sequencing and genetic analysis are sold to the life sciences market throughout the world.

Elazar RabbaniChairman/CEO/Secretary/FounderBarry W WeinerPresident/CFO/Treas/Founder
James M O'BrienSenior VP:FinanceHerbert B BassVP:Finance
More Company Profile & Key Executives for ENZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil